Literature DB >> 24927825

Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.

Christopher Akolo1, Walter Royal, Mariana Cherner, Kanayo Okwuasaba, Lindsay Eyzaguirre, Ruxton Adebiyi, Anya Umlauf, Terence Hendrix, Joyce Johnson, Alashl'e Abimiku, William A Blattner.   

Abstract

Detailed neuropsychological testing was performed on 133 human immunodeficiency virus (HIV) seropositive (SP) and 77 HIV seronegative (SN) individuals, 86 % with early stage HIV infection in Nigeria, to determine the frequency of HIV-related neurocognitive impairment among the HIV-infected group. The tests were administered to assess the following seven ability domains: speed of information processing, attention/working memory, executive functioning, learning, memory, verbal fluency, and motor function motor. Demographically corrected individual test scores and scores for each domain or reflecting a global deficit (a global deficit score, or GDS) were compared for the SP and SN groups. SP participants were older, had fewer years of education, were more likely to be married, differed in ethnicity, and had higher depression scores than SN individuals. Within the seven ability domains, SP performed worse than SN with respect to speed of information processing, executive function, learning, memory, and verbal fluency and also on the global measure. SP were also more frequently impaired on tests of SIP, and there was a borderline increase in the frequency of global impairment. On the individual tests, SP performed worse than SN on four tests that assessed learning, verbal fluency, memory, and motor function (the Timed Gait). SP subjects, however, performed better than SN on the Finger-tapping test, also a motor task. Performance by SP subjects was not associated on the timed gait which showed a borderline statistically significant correlation with CD4 counts. However, there were significant correlations between viral load measurements and individual tests of speed of information processing, executive function, learning, and verbal fluency and with overall executive function and a borderline correlation with the GDS. Depression scores for SP were associated with impairment on only a single test of executive function. These results demonstrate the ability of these assessments to identify areas of impairment that may be specifically linked to a history of HIV infection among individuals in Nigeria. Confirmation of these findings awaits analyses using data from a larger number of control subjects.

Entities:  

Mesh:

Year:  2014        PMID: 24927825      PMCID: PMC4312476          DOI: 10.1007/s13365-014-0254-6

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  24 in total

1.  Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy.

Authors:  Gregory J Dore; Ann McDonald; Yueming Li; John M Kaldor; Bruce J Brew
Journal:  AIDS       Date:  2003-07-04       Impact factor: 4.177

2.  Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Raul Gonzalez; Emily Conover; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

Review 3.  Neurologic manifestations of AIDS.

Authors:  J C McArthur
Journal:  Medicine (Baltimore)       Date:  1987-11       Impact factor: 1.889

Review 4.  Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.

Authors:  Avi Nath
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

5.  Community screening interview for dementia (CSI 'D'); performance in five disparate study sites.

Authors:  K S Hall; S Gao; C L Emsley; A O Ogunniyi; O Morgan; H C Hendrie
Journal:  Int J Geriatr Psychiatry       Date:  2000-06       Impact factor: 3.485

6.  Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging.

Authors:  I Grant; J H Atkinson; J R Hesselink; C J Kennedy; D D Richman; S A Spector; J A McCutchan
Journal:  Ann Intern Med       Date:  1987-12       Impact factor: 25.391

7.  Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome.

Authors:  J R Berger; L Moskowitz; M Fischl; R E Kelley
Journal:  South Med J       Date:  1987-06       Impact factor: 0.954

8.  Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients.

Authors:  W D Snider; D M Simpson; S Nielsen; J W Gold; C E Metroka; J B Posner
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

Review 9.  HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes.

Authors:  Eric Anderson; Walter Zink; Huangui Xiong; Howard E Gendelman
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

10.  Dementia prevalence estimates in sub-Saharan Africa: comparison of two diagnostic criteria.

Authors:  Stella-Maria Paddick; Anna R Longdon; Aloyce Kisoli; Catherine Dotchin; William K Gray; Felicity Dewhurst; Paul Chaote; Raj Kalaria; Ahmed M Jusabani; Richard Walker
Journal:  Glob Health Action       Date:  2013-04-03       Impact factor: 2.640

View more
  20 in total

1.  Cognitive Function Among Antiretroviral Treatment-Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria.

Authors:  Jibreel Jumare; Nicaise Ndembi; Samer S El-Kamary; Laurence Magder; Laura Hungerford; Tricia Burdo; Lindsay M Eyzaguirre; Patrick Dakum; Anya Umlauf; Mariana Cherner; Alash'le Abimiku; Man Charurat; William A Blattner; Walter Royal
Journal:  Clin Infect Dis       Date:  2018-04-17       Impact factor: 9.079

2.  Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria.

Authors:  Jibreel Jumare; Sara Sunshine; Hayat Ahmed; Samer S El-Kamary; Laurence Magder; Laura Hungerford; Tricia Burdo; Lindsay M Eyzaguirre; Anya Umlauf; Mariana Cherner; Alash'le Abimiku; Man Charurat; Jonathan Z Li; William A Blattner; Walter Royal
Journal:  J Neurovirol       Date:  2017-02-27       Impact factor: 2.643

3.  Assessment of neurocognitive deficits in people living with HIV in Sub Saharan Africa: A systematic review.

Authors:  Primrose Nyamayaro; Dixon Chibanda; Reuben N Robbins; James Hakim; Hetta Gouse
Journal:  Clin Neuropsychol       Date:  2019-05-01       Impact factor: 3.535

Review 4.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

5.  Neurocognitive functioning among HIV-positive adults in southern India.

Authors:  Rujvi Kamat; Allen McCutchan; Nagalingeswaran Kumarasamy; Thomas D Marcotte; Anya Umlauf; Poongulali Selvamuthu; Rachel Meyer; Scott Letendre; Robert Heaton; Ajay R Bharti
Journal:  J Neurovirol       Date:  2017-07-05       Impact factor: 2.643

Review 6.  Physical function, grip strength and frailty in people living with HIV in sub-Saharan Africa: systematic review.

Authors:  Charlotte Bernard; François Dabis; Nathalie de Rekeneire
Journal:  Trop Med Int Health       Date:  2017-03-08       Impact factor: 2.622

7.  Cognitive performance in a South African cohort of people with HIV and comorbid major depressive disorder.

Authors:  Anna J Dreyer; Sam Nightingale; Lena S Andersen; Jasper S Lee; Hetta Gouse; Steven A Safren; Conall O'Cleirigh; Kevin G F Thomas; John Joska
Journal:  J Neurovirol       Date:  2022-09-01       Impact factor: 3.739

8.  Female sex is strongly associated with cognitive impairment in HIV infection.

Authors:  Eric Andrius Coelho Duarte; Maria Luiza Benevides; André Luiz Pereira Martins; Edson Pillotto Duarte; Ana Beatriz Santandrea Weller; Laura Oliveira Coutinho de Azevedo; Maria Emília Rodrigues de Oliveira Thaís; Jean Costa Nunes
Journal:  Neurol Sci       Date:  2020-09-14       Impact factor: 3.307

9.  Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria.

Authors:  Jibreel Jumare; Samer S El-Kamary; Laurence Magder; Laura Hungerford; Nicaise Ndembi; Ahmad Aliyu; Patrick Dakum; Anya Umlauf; Mariana Cherner; Alash'le Abimiku; Man Charurat; William A Blattner; Walter Royal
Journal:  J Neurovirol       Date:  2018-08-30       Impact factor: 2.643

Review 10.  Changing clinical phenotypes of HIV-associated neurocognitive disorders.

Authors:  Ned Sacktor
Journal:  J Neurovirol       Date:  2017-07-27       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.